Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Riess

Showing results (1081-1090 of 1,489) with videos related to

Pageof 149
Sort By:
JAMA|October 10, 2013
Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trialHelmut Oettle, Peter Neuhaus, Andreas Hochhaus, et al.
BMC Public Health|September 3, 2020
Publisher Correction to: Protocol of a population-based prospective COVID-19 cohort study Munich, Germany (KoCo19)Katja Radon, Elmar Saathoff, Michael Pritsch, et al.
JCO Precision Oncology|July 12, 2021
Plasma ctDNA Response Is an Early Marker of Treatment Effect in Advanced NSCLCMichael L Cheng, Christie J Lau, Marina S D Milan, et al.
Experimental Neurology|May 31, 2008
Parkinson patient fibroblasts show increased alpha-synuclein expressionHans-Hermann Hoepken, Suzana Gispert, Mekhman Azizov, et al.
British Journal of Cancer|May 15, 2018
Tumour buds determine prognosis in resected pancreatic ductal adenocarcinomaPhilipp Lohneis, Marianne Sinn, Fritz Klein, et al.
Journal of Clinical Medicine|August 26, 2022
Dual Targeting of the EGFR/HER2 Pathway in Combination with Systemic Chemotherapy in Refractory Pancreatic Cancer-The CONKO-008 Phase I InvestigationJana K Striefler, Jens M Stieler, Christopher C M Neumann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2018
Safety of Programmed Death-1 Pathway Inhibitors Among Patients With Non-Small-Cell Lung Cancer and Preexisting Autoimmune DisordersGiulia C Leonardi, Justin F Gainor, Mehmet Altan, et al.
Pathology, Research and Practice|July 28, 2016
P53 overexpression and Ki67-index are associated with outcome in ductal pancreatic adenocarcinoma with adjuvant gemcitabine treatmentJana K Striefler, Marianne Sinn, Uwe Pelzer, et al.
Forschende Komplementarmedizin (2006)|November 9, 2013
Network Oncology (NO)--a clinical cancer register for health services research and the evaluation of integrative therapeutic interventions in anthroposophic medicineFriedemann Schad, Jan Axtner, Antje Happe, et al.
Frontiers in Behavioral Neuroscience|October 18, 2013
Modified impact of emotion on temporal discrimination in a transgenic rat model of Huntington diseaseAlexis Faure, Mouna Es-Seddiqi, Bruce L Brown, et al.
Pageof 149

Showing results (1081-1090 of 1,489) with videos related to

Sort By:
Pageof 149
JAMA|October 10, 2013
Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trialHelmut Oettle, Peter Neuhaus, Andreas Hochhaus, et al.
BMC Public Health|September 3, 2020
Publisher Correction to: Protocol of a population-based prospective COVID-19 cohort study Munich, Germany (KoCo19)Katja Radon, Elmar Saathoff, Michael Pritsch, et al.
JCO Precision Oncology|July 12, 2021
Plasma ctDNA Response Is an Early Marker of Treatment Effect in Advanced NSCLCMichael L Cheng, Christie J Lau, Marina S D Milan, et al.
Experimental Neurology|May 31, 2008
Parkinson patient fibroblasts show increased alpha-synuclein expressionHans-Hermann Hoepken, Suzana Gispert, Mekhman Azizov, et al.
British Journal of Cancer|May 15, 2018
Tumour buds determine prognosis in resected pancreatic ductal adenocarcinomaPhilipp Lohneis, Marianne Sinn, Fritz Klein, et al.
Journal of Clinical Medicine|August 26, 2022
Dual Targeting of the EGFR/HER2 Pathway in Combination with Systemic Chemotherapy in Refractory Pancreatic Cancer-The CONKO-008 Phase I InvestigationJana K Striefler, Jens M Stieler, Christopher C M Neumann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2018
Safety of Programmed Death-1 Pathway Inhibitors Among Patients With Non-Small-Cell Lung Cancer and Preexisting Autoimmune DisordersGiulia C Leonardi, Justin F Gainor, Mehmet Altan, et al.
Pathology, Research and Practice|July 28, 2016
P53 overexpression and Ki67-index are associated with outcome in ductal pancreatic adenocarcinoma with adjuvant gemcitabine treatmentJana K Striefler, Marianne Sinn, Uwe Pelzer, et al.
Forschende Komplementarmedizin (2006)|November 9, 2013
Network Oncology (NO)--a clinical cancer register for health services research and the evaluation of integrative therapeutic interventions in anthroposophic medicineFriedemann Schad, Jan Axtner, Antje Happe, et al.
Frontiers in Behavioral Neuroscience|October 18, 2013
Modified impact of emotion on temporal discrimination in a transgenic rat model of Huntington diseaseAlexis Faure, Mouna Es-Seddiqi, Bruce L Brown, et al.
Pageof 149